Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Gilenya prescribing information
First NW patient to receive OHSU/VAMC-invented MS drug
Laquinimod - New Promising Treatment for Multiple Sclerosis
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
Liposarcoma concurrence in a multiple sclerosis patient treated with interferon-beta 1b.
A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients - A twelve month follow-up.
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Patients with migraine do not have MRI-visible cortical lesions.
Mycoplasma pneumonia seroposivity in Iranian patients with relapsing-remitting multipl sclerosis: a randomized case-control study.
Expression and activation by epstein barr virus of human endogenous retroviruses-w in blood cells and astrocytes: inference for multiple sclerosis.
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Arzerra receives approval in Japan
Calcitriol Modulates the CD46 Pathway in T Cells.
Long term lymphocyte reconstitution after alemtuzumab treatment of multiple sclerosis.
Glatiramer acetate (copaxone) modulates platelet activation and inhibits thrombin-induced calcium influx: possible role of copaxone in targeting platelets during autoimmune neuroinflammation.
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Amyloid precursor protein at node of Ranvier modulates nodal formation.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes.

Pages